Ligand validation:7WW9

8DG: 8-OXO-2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE

8DG is a Ligand Of Interest in 7WW9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7WW9_8DG_A_201	76%	14%	0.113	0.949	1.47	2.37	5	12	0	0	100%	0.2
7X9H_8DG_A_202	93%	22%	0.075	0.969	0.97	2.26	2	13	0	0	100%	0.7
7X9I_8DG_A_202	91%	19%	0.084	0.972	0.95	2.44	3	14	0	0	100%	0.3
7WW7_8DG_A_201	89%	15%	0.082	0.96	1.46	2.32	3	9	0	0	100%	1
7WW8_8DG_A_202	88%	14%	0.086	0.961	1.47	2.34	5	10	0	0	100%	1
7WW6_8DG_A_201	87%	26%	0.087	0.958	1	1.95	2	10	0	0	100%	0.9375
7KT3_8DG_A_501	98%	29%	0.058	0.984	1.24	1.57	4	5	0	0	100%	1
7KTJ_8DG_A_506	98%	43%	0.064	0.987	0.86	1.32	-	3	0	0	100%	1
5GG6_8DG_A_401	98%	8%	0.059	0.979	2.02	2.55	6	12	0	0	100%	1
4XA5_8DG_A_601	94%	8%	0.064	0.963	2.14	2.42	8	12	0	0	100%	0.94
5GG8_8DG_A_401	94%	6%	0.079	0.978	1.97	2.97	6	12	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.